0001493152-21-006309.txt : 20210318 0001493152-21-006309.hdr.sgml : 20210318 20210318122107 ACCESSION NUMBER: 0001493152-21-006309 CONFORMED SUBMISSION TYPE: 1-A/A PUBLIC DOCUMENT COUNT: 15 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovega Inc. CENTRAL INDEX KEY: 0001474232 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 800203668 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 1-A/A SEC ACT: 1933 Act SEC FILE NUMBER: 024-11441 FILM NUMBER: 21753671 BUSINESS ADDRESS: STREET 1: 11900 NE 1ST STREET STREET 2: SUITE 300 CITY: BELLEVUE STATE: WA ZIP: 98005 BUSINESS PHONE: 425-516-8175 MAIL ADDRESS: STREET 1: 11900 NE 1ST STREET STREET 2: SUITE 300 CITY: BELLEVUE STATE: WA ZIP: 98005 1-A/A 1 primary_doc.xml 1-A/A LIVE 0001474232 XXXXXXXX 024-11441 true true Innovega Inc. DE 2008 0001474232 8731 80-0203668 7 2 11900 E 1st Street Bellevue WA 98005 425-516-8175 Greg Sichenzia Other 1682476.00 0.00 0.00 500466.00 2182942.00 770746.00 4021153.00 4791899.00 -2608957.00 2182942.00 0.00 0.00 65111.00 -1745437.00 0.19 0.19 FRUCI & ASSOCIATES II, PLLC Common Stock 9447968 000000000 N/A Common Warrants 132514 000000000 N/A Series Seed Preferred Stock 3518238 000000000 N/A N/A 0 000000000 N/A true true Tier2 Audited Equity (common or preferred stock) Y N N Y Y N 5000000 0 3.0000 15000000.00 0.00 0.00 0.00 15000000.00 SI Securities, LLC 1275000.00 Fruci & Associates II, PLLC 22000.00 Sichenzia Ross Ference LLP 75000.00 291773 13628000.00 true AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PR AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PR Innovega Inc. Common stock and SAFE Notes 1832275 0 0 These securities were sold in reliance upon the exemption provided by Section 4(a)(2) of the Securities Act for transactions not involving a public offering. PART II AND III 2 partiiandiii.htm

Innovega Inc. (the “Company”) has prepared this Form1-A/A solely for the purpose of filing Exhibits 13.4 through 13.6.

PART III

INDEX TO EXHIBITS

1.1	Issuer Agreement with SI Securities, LLC*

2.1	Second Amended and Restated Certificate of Incorporation*

2.2	Bylaws*

3.1	Form of Amended and restated Stockholders’ Agreement*

3.2	Amendment to 2019 Convertible Promissory Notes*

3.3	Note Purchase Agreement dated as of January 22, 2019, among Innovega Inc. and the investors named therein*

3.4	Form of Simple Agreement for future Equity*

3.5	Form of Note Conversion Acknowledgment*

3.6	Form of SAFE Conversion Acknowledgment*

3.7	Amendment to SAFE Notes Agreement*

4	Form of Subscription Agreement*

6.1	Innovega Inc. 2008 Equity Incentive Plan*

8.1	Form of Escrow Agreement*

11	Auditor’s Consent*

12	Opinion of Sichenzia Ross Ference LLP*

13.1	Innovega Highlights*

13.2	Innovega Profile and Offering Summary*

13.3	Innovega Private Reservation Launch*

13.4	Weekly Deal Newsletter

13.5	Reservation Transactional

13.6	Weekly Highlights

Previously filed

Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in San Diego, State of California, on March 18, 2021.

INNOVEGA INC.

By:	/s/ Stephen Willey
	Stephen Willey
	Chief Executive Officer

The following persons in the capacities and on the dates indicated have signed this Offering Statement.

/s/ Stephen Willey	March 18, 2021
Stephen Willey
Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Director

/s/ Jerome Legerton
Jerome Legerton	March 18, 2021
Chief Clinical & Regulatory Officer, Secretary, Director

/s/ Shane Kim	March 18, 2021
Shane Kim
Director

/s/ Jeff Bradley	March 18, 2021
Jeff Bradley
Director

EX1A-13 TST WTRS 3 ex13-4.htm

Exhibit 13.4

EX1A-13 TST WTRS 4 ex13-5.htm

Exhibit 13.5

EX1A-13 TST WTRS 5 ex13-6.htm

Exhibit 13.6

GRAPHIC 6 ex13-4_001.jpg begin 644 ex13-4_001.jpg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

K M41%C140850 !Z"G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9 end